{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:00Z","timestamp":1759336260071,"version":"3.37.3"},"reference-count":59,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T00:00:00Z","timestamp":1496361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178626","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T17:47:25Z","timestamp":1496425645000},"page":"e0178626","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adverse drug events\u2014Analysis of a decade. A Portuguese case-study, from 2004 to 2013 using hospital database"],"prefix":"10.1371","volume":"12","author":[{"given":"Gianina","family":"Scripcaru","sequence":"first","affiliation":[]},{"given":"Ceu","family":"Mateus","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4562-1057","authenticated-orcid":true,"given":"Carla","family":"Nunes","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2017,6,2]]},"reference":[{"key":"ref1","unstructured":"Organization WH. Pharmacovigilance Toolkit [cited 2015 31 July]. Available from: http:\/\/pvtoolkit.org\/pv-toolkit-2\/#tab-id-2<\/ext-link>"},{"issue":"8","key":"ref2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/pds.3296","article-title":"Terms used in patient safety related to medication: a literature review","volume":"21","author":"A Pintor-Marmol","year":"2012","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"ref3","unstructured":"C\u00f3digo comunit\u00e1rio relativo aos medicamentos para uso humano. DIRECTIVA 2010\/84\/UE DO PARLAMENTO EUROPEU E DO CONSELHO [Internet]. 2010 [cited 2013 15 October]: [74\u201399 pp.]. Available from: http:\/\/ec.europa.eu\/health\/files\/eudralex\/vol-1\/dir_2010_84\/dir_2010_84_pt.pdf<\/ext-link>."},{"key":"ref4","unstructured":"Hougland P, Nebeker J, Pickard S, Van Tuinen M, Masheter C, Elder S, et al. Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance. In: Henriksen K, Battles JB, Keyes MA, Grady ML, editors. Advances in Patient Safety: New Directions and Alternative Approaches (Vol 1: Assessment). Advances in Patient Safety. Rockville (MD)2008."},{"key":"ref5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1472-6963-14-125","article-title":"International prevalence of adverse drug events in hospitals: an analysis of routine data from England, Germany, and the USA","volume":"14","author":"J Stausberg","year":"2014","journal-title":"BMC health services research"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2125.1998.00685.x","article-title":"Computerized survelliance of adverse drug reactions in hospital: pilot study","volume":"45","author":"T Azaz-Livshits","year":"1998","journal-title":"British journal of clinical pharmacology"},{"issue":"20","key":"ref7","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1001\/jama.1991.03470200059035","article-title":"Computerized surveillance of adverse drug events in hospital patients","volume":"266","author":"DC Classen","year":"1991","journal-title":"Jama"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF00315383","article-title":"Drug related hospital admissions. Results from an intervention program","volume":"45","author":"J Hallas","year":"1993","journal-title":"European journal of clinical pharmacology"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002280050738","article-title":"Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability","volume":"56","author":"R Lagnaoui","year":"2000","journal-title":"European journal of clinical pharmacology"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2710.2006.00744.x","article-title":"Adverse drug reactions in hospital in-patients: a pilot study","volume":"31","author":"EC Davies","year":"2006","journal-title":"Journal of clinical pharmacy and therapeutics"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11096-010-9372-2","article-title":"Detection of adverse drug reactions through the minimum basic data set","volume":"32","author":"A Salmeron-Garcia","year":"2010","journal-title":"Pharmacy world & science: PWS"},{"issue":"21","key":"ref12","first-page":"969","article-title":"Hypertensive encephalopathy: does not only occur at high blood pressure","volume":"146","author":"CA Wijman","year":"2002","journal-title":"Nederlands tijdschrift voor geneeskunde"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","article-title":"Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands","volume":"29","author":"CS van der Hooft","year":"2006","journal-title":"Drug safety"},{"issue":"7456","key":"ref14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"M Pirmohamed","year":"2004","journal-title":"Bmj"},{"issue":"7241","key":"ref15","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","article-title":"Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres","volume":"320","author":"P Pouyanne","year":"2000","journal-title":"Bmj"},{"issue":"9","key":"ref16","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1345\/aph.1A333","article-title":"Hospital admissions resulting from preventable adverse drug reactions","volume":"36","author":"PJ McDonnell","year":"2002","journal-title":"The Annals of pharmacotherapy"},{"key":"ref17","unstructured":"Tisdale JE, Miller DA, Pharmacists ASoH-S. Drug-induced Diseases: Prevention, Detection, and Management. American Society of Health-System Pharmacists; 2010. p. 14\u201322."},{"key":"ref18","unstructured":"Mackichan JJ, Lee WLM. Factors Contributing to Drug-Induced Diseases. In: Tisdale JE, Miller DA, Pharmacists ASoH-S, editors. Drug-induced Diseases: Prevention, Detection, and Management: American Society of Health-System Pharmacists; 2010. p. 23\u201330."},{"issue":"7\u20138","key":"ref19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1345\/aph.1E642","article-title":"Risk factors for adverse drug events: a 10-year analysis","volume":"39","author":"RS Evans","year":"2005","journal-title":"The Annals of pharmacotherapy"},{"issue":"21","key":"ref20","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/archinte.159.21.2553","article-title":"Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group","volume":"159","author":"DW Bates","year":"1999","journal-title":"Archives of internal medicine"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1023\/A:1008721321016","article-title":"Risk factors for the development of adverse drug events in hospitalized patients","volume":"22","author":"PM van den Bemt","year":"2000","journal-title":"Pharmacy world & science: PWS"},{"issue":"8","key":"ref22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/pds.3468","article-title":"Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal","volume":"22","author":"A Miguel","year":"2013","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/pds.1984","article-title":"Adverse drug events in the outpatient setting: an 11-year national analysis","volume":"19","author":"FT Bourgeois","year":"2010","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"JR Nebeker","year":"2004","journal-title":"Annals of internal medicine"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5694\/j.1326-5377.2005.tb06698.x","article-title":"Adverse drug reactions in older Australians, 1981\u20132002","volume":"182","author":"CL Burgess","year":"2005","journal-title":"The Medical journal of Australia"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1258\/jrsm.2010.100113","article-title":"Ten-year trends in hospital admissions for adverse drug reactions in England 1999\u20132009","volume":"103","author":"TY Wu","year":"2010","journal-title":"Journal of the Royal Society of Medicine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"S360","DOI":"10.1590\/S0102-311X2009001500003","article-title":"Adverse drug events in hospitals: a systematic review","volume":"25","author":"FG Cano","year":"2009","journal-title":"Cadernos de Sa\u00fade P\u00fablica"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/pds.3309","article-title":"Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis","volume":"21","author":"A Miguel","year":"2012","journal-title":"Pharmacoepidemiology and drug safety"},{"key":"ref29","first-page":"91","article-title":"Stephens' Detection of New Adverse Drug Reactions","author":"P Routledge","year":"2004"},{"issue":"2","key":"ref30","first-page":"83","article-title":"Factors affecting the development of adverse drug reactions (Review article)","volume":"22","author":"MJ Alomar","year":"2014","journal-title":"Saudi pharmaceutical journal: SPJ: the official publication of the Saudi Pharmaceutical Society"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"e24061","DOI":"10.1371\/journal.pone.0024061","article-title":"Adverse drug reactions in children\u2014a systematic review","volume":"7","author":"RM Smyth","year":"2012","journal-title":"PloS one"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/gerona\/glr233","article-title":"Polypharmacy in nursing home in Europe: results from the SHELTER study","volume":"67","author":"G Onder","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ageing\/29.1.35","article-title":"Contribution of adverse drug reactions to hospital admission of older patients","volume":"29","author":"CK Mannesse","year":"2000","journal-title":"Age Ageing"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00228-013-1630-5","article-title":"Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission","volume":"70","author":"C Pedros","year":"2014","journal-title":"European journal of clinical pharmacology"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/08923970903468847","article-title":"Adverse drug reactions as the cause of emergency department admission: focus on the elderly","volume":"32","author":"MT Ventura","year":"2010","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1590\/S1984-82502009000100020","article-title":"Contribui\u00e7\u00e3o do uso de medicamentos para a admiss\u00e3o hospitalar","volume":"45","author":"PdC Mastroianni","year":"2009","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002512-200926060-00004","article-title":"Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey","volume":"26","author":"P Olivier","year":"2009","journal-title":"Drugs Aging"},{"issue":"7","key":"ref38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejim.2007.06.030","article-title":"Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece","volume":"19","author":"A Alexopoulou","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/BF03261973","article-title":"Incidence and economic burden of adverse drug reactions among elderly patients in Ontario emergency departments: a retrospective study","volume":"35","author":"C Wu","year":"2012","journal-title":"Drug safety"},{"issue":"6","key":"ref40","first-page":"545","article-title":"Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients","volume":"31","author":"M Franceschi","year":"2008","journal-title":"Drug safety"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/01.mjt.0000183719.84390.4d","article-title":"Pharmacokinetic-pharmacodynamic crisis in the elderly","volume":"14","author":"ES ElDesoky","year":"2007","journal-title":"Am J Ther"},{"issue":"17","key":"ref42","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1093\/ajhp\/60.17.1750","article-title":"Nature of preventable adverse drug events in hospitals: a literature review","volume":"60","author":"P Kanjanarat","year":"2003","journal-title":"American journal of health-system pharmacy: AJHP: official journal of the American Society of Health-System Pharmacists"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1060028013504904","article-title":"Association between potentially inappropriate medications from the Beers criteria and the risk of unplanned hospitalization in elderly patients","volume":"48","author":"SD Price","year":"2014","journal-title":"The Annals of pharmacotherapy"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1365-2125.2009.03531.x","article-title":"Potentially inappropriate prescribing in an Irish elderly population in primary care","volume":"68","author":"C Ryan","year":"2009","journal-title":"British journal of clinical pharmacology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/CIA.S99097","article-title":"Hospitalization in older patients due to adverse drug reactions -the need for a prediction tool","volume":"11","author":"N Parameswaran Nair","year":"2016","journal-title":"Clin Interv Aging"},{"issue":"9","key":"ref46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/00002512-200522090-00005","article-title":"Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause","volume":"22","author":"MC Passarelli","year":"2005","journal-title":"Drugs Aging"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00228-002-0535-5","article-title":"Reporting adverse drug reactions on a geriatric ward: a pilot project","volume":"58","author":"A Somers","year":"2003","journal-title":"European journal of clinical pharmacology"},{"issue":"10","key":"ref48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","article-title":"Women encounter ADRs more often than do men","volume":"64","author":"Y Zopf","year":"2008","journal-title":"European journal of clinical pharmacology"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s13054-014-0643-5","article-title":"A systematic review of adult admissions to ICUs related to adverse drug events","volume":"18","author":"PA Jolivot","year":"2014","journal-title":"Crit Care"},{"issue":"15","key":"ref50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","article-title":"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies","volume":"279","author":"J Lazarou","year":"1998","journal-title":"Jama"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"29","author":"L Hazell","year":"2006","journal-title":"Drug safety"},{"issue":"4","key":"ref52","first-page":"83","article-title":"Physician code creep: evidence in Medicaid and State Employee Health Insurance billing","volume":"28","author":"EE Seiber","year":"2007","journal-title":"Health care financing review"},{"issue":"11","key":"ref53","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2165\/00002018-200730110-00006","article-title":"Factors that influence under-reporting of suspected adverse drug reactions among community pharmacists in a Spanish region","volume":"30","author":"M Irujo","year":"2007","journal-title":"Drug safety"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jcph.149","article-title":"Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital","volume":"53","author":"LH Goldstein","year":"2013","journal-title":"Journal of clinical pharmacology"},{"issue":"8","key":"ref55","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF03261962","article-title":"Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal","volume":"35","author":"MT Herdeiro","year":"2012","journal-title":"Drug safety"},{"issue":"12","key":"ref56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/pds.2193","article-title":"The lack of knowledge about the voluntary reporting system of adverse drug reactions as a major cause of underreporting: direct survey among health professionals","volume":"20","author":"M Perez Garcia","year":"2011","journal-title":"Pharmacoepidemiology and drug safety"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12968\/bjon.2013.22.8.484","article-title":"Nurses must report adverse drug reactions","volume":"22","author":"R Griffith","year":"2013","journal-title":"British journal of nursing (Mark Allen Publishing)"},{"key":"ref58","first-page":"63","article-title":"Using patient-reported experiences for pharmacovigilance?","volume":"194","author":"SA Adams","year":"2013","journal-title":"Studies in health technology and informatics"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00002018-200326050-00004","article-title":"Lack of awareness of community-acquired adverse drug reactions upon hospital admission: dimensions and consequences of a dilemma","volume":"26","author":"H Dormann","year":"2003","journal-title":"Drug safety"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T14:54:52Z","timestamp":1719240892000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178626"}},"subtitle":[],"editor":[{"given":"Alessandra","family":"Marengoni","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2017,6,2]]},"references-count":59,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178626","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,6,2]]}}}